Position in PRGO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,415,515
-$883,631 QoQ
Shares Held
328,731
-17.9% QoQ
Ownership
0.237%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#57
of 334 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 83%
Shared 0%
None 17%
Common Shares in PRGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Aristotle Capital Boston, LLC holds $21,351,066 across 3 Drug Manufacturers - Specialty & Generic names. PRGO ranks #3 (16.0% of the industry book) .
All Filings in PRGO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,415,515 | 328,731 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,299,146 | 400,293 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,409,116 | 460,425 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $11,293,250 | 507,106 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,693,370 | 400,201 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,170,566 | 220,063 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||